Delivery Order SPE2DB24D2106-SPE2DB25FAURJ

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Department of Defense's Medical Supply Chain. The single-award indefinite delivery contract, valued at up to $3,078.84, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. It enables the DLA to place firm fixed-price delivery orders for a broad range of pharmaceutical items to support the recurring medical supply needs of...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The single-award contract, valued up to $10,948.83, is a delivery order for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a firm fixed price pricing type and an ultimate completion date of April 5, 2024. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDV) with the DLA, contract SPE2DB24D2106,...
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $15,751.69 firm fixed-price delivery order is for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The delivery order was issued against an indefinite delivery vehicle (IDV) contract, SPE2DB24D2106|SPE2DB24FAUAA, with a ceiling value of up to $4,999,999 through 2025. This IDV contract enables DLA to place orders for a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $55,064.59 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products to fulfill the...
This federal contract award, valued at $32,628.10, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award, valued at $4,697.76, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. This award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $47,563.78 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,437.68 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award, valued at $24,415.69, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the HUMIRA(CF) PEN 40 MG/0.4 MLS medication, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award provides a delivery order for HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $40,753.04 firm fixed-price contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a completion date of May 9, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAURJ
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $16,482.31 for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The award was made by the Defense Logistics Agency (DLA), a defense agency, on February 26, 2025, with a completion date of February 27, 2025. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal government agencies. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide variety of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 5/28/25, 10:56 AM